Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Public sources
Chapter 2 Executive Summary
2.1 Psychedelic Mushroom Market 360º synopsis, 2018 - 2032
2.2 Business trends
2.2.1 Total Addressable Market (TAM), 2023 - 2032
2.3 Regional trends
2.4 Product trends
2.5 Form trends
2.6 Application trends
Chapter 3 Psychedelic Mushroom Market Industry Insights
3.1 Impact of COVID-19
3.2 Impact of the Russia-Ukraine war
3.3 China-U.S. trade war impact
3.4 Industry ecosystem analysis
3.5 Type & innovation landscape
3.6 Patent analysis
3.7 Key news and initiatives
3.7.1 Partnership/Collaboration
3.7.2 Merger/Acquisition
3.7.3 Investment
3.7.4 Product launch & innovation
3.8 Regulatory landscape
3.9 Impact forces
3.9.1 Growth drivers
3.9.2 Industry pitfalls & challenges
3.10 Growth potential analysis
3.11 Porter’s analysis
3.12 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company market share, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic outlook matrix, 2022
Chapter 5 Psychedelic Mushroom Market Estimates & Forecast, By Product
5.1 Key trends, By Product Type
5.2 Psilocybe
5.3 Gymnopilus
5.4 Panaeolus
Chapter 6 Psychedelic Mushroom Market Estimates & Forecast, By Form
6.1 Key trends, By Form
6.2 Fresh/Whole
6.3 Dried
6.4 Processed
Chapter 7 Psychedelic Mushroom Market Estimates & Forecast, By Application
7.1 Key trends, By Application
7.2 De-addiction
7.3 Recreational
7.4 Therapeutic
Chapter 8 Psychedelic Mushroom Market Estimates & Forecast, By Region
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 UK
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Spain
8.4 Asia Pacific
8.4.1 China
8.4.2 India
8.4.3 Japan
8.4.4 South Korea
8.4.5 Indonesia
8.4.6 Australia
8.4.7 Malaysia
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.6 MEA
8.6.1 UAE
8.6.2 Saudi Arabia
8.6.3 South Africa
8.6.4 Egypt
Chapter 9 Company Profiles
9.1 Compass Pathways
9.2 MindMed
9.3 Field Trip Health
9.4 Atai Life Sciences
9.5 Cybin Inc.
9.6 Mydecine Innovations Group
9.7 Revive Therapeutics
9.8 Numinus Wellness
